CooperSurgical Inc.

Company Snapshot

Founded: 1990
Entity Type: Private
Region: U.S.
Headquarter: Connecticut, U.S.
Key Geographics: North America, Europe, Asia-Pacific, Middle-East
Corporate Address: 75 Corporate Drive Trumbull Connecticut 06611 U.S. Tel. +1-203-601-5200 www.coopersurgical.com

Company Overview

CooperSurgical Inc. provides point-of-care diagnostic tools and assays, newborn and adult critical care instruments and surgical instruments for obstetrics and gynecology. Through two of its acquired businesses, Origio (an IVF technology firm) and Reprogenetics (a preimplantation genetic diagnosis company), Cooper Surgical also provides assisted reproductive services. The company’s advanced IVF product and service portfolio includes reproductive genomics, media, devices, equipment, cryo storage and logistics. It offers fertility healthcare professionals superior solutions for each stage of the IVF process.

CooperSurgical Inc. In Reports

Global Assisted Reproductive Technologies Market

BCC Research Market Analyst says global market for assisted reproductive technologies was valued at an estimated $35.4 billion in 2024 and is slated to reach $53.8 billion by the end of 2030.

Fetal Monitoring, Diagnostics and Predictive Tests

BCC Research Market Report says fetal monitoring diagnostics and predictive tests is estimated to increase from $10.4 bln in 2022 to reach $13.6 bln by 2027 at a CAGR of 5.6%

Human Reproductive Technologies: Products and Global Markets

BCC Research Market Analysis Report Says human reproductive technologies and products is valued at $16.1 bln in 2021 and is estimated to grow from $17.1 bln in 2022 to $24 bln in 2027.

Company's Business Segments

  • Fertility and Women Health : The company offers surgical and medical products and brands, ranging from reproductive care to fertility, birth, and women’s health care, such as obstetrics and gynecology, and other clinicians.

Applications/End User Industries

  • Healthcare
  • Life Sciences
AI Sentiment